Molecular alterations and poziotinib efficacy, a pan-HER inhibitor, in human epidermal growth factor receptor 2 (HER2)-positive breast cancers: Combined exploratory biomarker analysis from a phase II clinical trial of poziotinib for refractory HER2-
| Image |  |
|---|---|
| Description | scientific article published on 27 February 2019 |
| Author/s |
author: Seock-Ah Im Yeon Hee Park |
| Publication date | February 27, 2019 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |